Exploring New Modality Space by Precision Chemistry

Confirmed Speakers


Keynote Speaker

Transforming the Therapeutic Landscape with New Chemical Modalities (KL01)
Dr Eric VALEURDr Eric VALEUR
(FLAGSHIP VENTURELABS, Cambridge, United States)

Read more

Invited Speakers

Activation of the Hippo Pathway via Targeting of Transcription Factor TEAD Using Designed Tertiary Protein Structure Mimetics (IL04)
Dr Hélène ADIHOUDr Hélène ADIHOU
(ASTRAZENECA, Strasbourg, France)

Read more
Targeting Non-Coding RNAs Using Synthetic Small Molecules: Scope and Applications (IL02)
Dr Maria DUCADr Maria DUCA
(UNIVERSITY OF CÔTE D'AZUR, Nice, France)

Read more
Targeting the Tumor Microenvironment for Therapeutic and Diagnostic Purposes (IL06)
Prof. Sebastien PAPOTProf. Sebastien PAPOT
(UNIVERSITY OF POITIERS, Poitiers, France)

Read more
Click-Cleavable Antibody-Drug Conjugates (IL05)
Dr Marc ROBILLARDDr Marc ROBILLARD
(TAGWORKS PHARMACEUTICALS, Eindhoven, The Netherlands)

Read more
Peptiligase Enzymes (IL03)
Dr Leendert VAN DEN BOSDr Leendert VAN DEN BOS
(ENZYTAG BV, Nuth, The Netherlands)

Read more
Enhancing Targeted Protein Degradation by Structure-Based PROTAC Design (IL01)
Dr Siying ZHONGDr Siying ZHONG
(UNIVERSITY OF DUNDEE, Dundee, United Kingdom)

Read more

Organised by

EFMC Certified Event

Copyright 2024 LD Organisation srl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys